Inspiren vs Sensi AI (2026)
If your failure mode is buying the broadest detection list without asking what validates it, or the tightest privacy story without checking it fits your setting, weigh these two carefully. They sense differently and sell to different buyers. Inspiren uses camera free skeletal imaging for senior living operators, tightly scoped to falls, behavior change, and care level accuracy, and it earns the lane's only A on privacy plus its most specific outcome evidence. Sensi AI uses audio pods and sells mainly to home care agencies, and its detection scope is far wider: alongside falls it flags possible urinary tract infections, pneumonia, early cognitive decline, and softer signals like sentiment and lack of companionship. The wider net is the appeal and the caution. Detecting pneumonia from audio is exactly the claim that warrants published sensitivity, which Sensi has not released.
- The tightest privacy posture in the lane: camera free skeletal imaging detects a fall without an identifiable image, the only A on privacy, which matters most in the bedroom setting Inspiren is built for.
- Bounded scope with the most specific evidence: a named ten month memory care study reporting a 48 percent fall reduction and a 54 percent hospitalization drop, against a broad detection list without a matching validation study.
- Built for senior living operators as a combined hardware, software, and clinical support package with a dedicated clinical specialist per community, if a facility rather than a home is your setting.
- The widest detection scope in the lane by design: more than 100 reported insights spanning falls, possible UTIs and pneumonia, early cognitive decline, and sentiment, with a clinical team across social work, OT, nursing, and geriatrics adding data points so the set stays grounded.
- The right fit if your buyer is a home care agency rather than a facility: Sensi reports serving 80 percent of the largest home care networks in North America, with audio chosen deliberately over cameras as less intrusive in a private home.
- Adoption signals genuine renewal rather than pilot churn: revenue reported tripling year over year for three consecutive years, which for a subscription product implies retention.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Inspiren and Sensi AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Inspiren | Sensi AI |
|---|---|---|
| Primary category | Home Care Operations | Home Care Operations |
| Founded | Not recorded | 2019 |
| Headquarters | Brooklyn, New York | Austin, Texas |
| Website | inspiren.com | sensi.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Inspiren its top capability grade on several axes, including AI Centrality, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Set against Sensi AI, Inspiren grades higher on Clinical and Operational Evidence and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Sensi AI its top capability grade on AI Centrality, HIPAA and BAA Posture and Setting and Specialty Coverage. Set against Inspiren, Sensi AI grades higher on HIPAA and BAA Posture and FDA and Regulatory Status. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Inspiren or Sensi AI?
On the axes where the AI Health Index separates them, Inspiren grades higher on Clinical and Operational Evidence and AI Safety and PHI Stewardship, and Sensi AI grades higher on HIPAA and BAA Posture and FDA and Regulatory Status. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.
Where do Inspiren and Sensi AI differ most?
The widest separation the AI Health Index records between Inspiren and Sensi AI is on HIPAA and BAA Posture, where Inspiren grades C and Sensi AI grades A. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Inspiren and Sensi AI grade the same?
The AI Health Index grades Inspiren and Sensi AI the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Inspiren and Sensi AI not disclosed?
At the last review, at least one of Inspiren and Sensi AI published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Home Care Operations page.
The two sense and sell differently, so the choice is rarely head to head on accuracy. Sensi's broad clinical detections, particularly UTI and pneumonia from audio, are graded on adoption not validation: no clinical sensitivity or specificity study was retrieved, and those claims warrant one.
On privacy, always on audio in a residence captures conversation from visitors and family who never consented, and Sensi has not disclosed retention, on device versus cloud processing, or third party consent handling, which is why it sits at B while Inspiren's skeletal imaging earns A. Inspiren's evidence is operator reported and not re verified here. Neither publishes a rate card; Sensi discloses the subscription model, Inspiren does not.